The chemical substance known as "(1S,4R)-1-(Hydroxymethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-4,6-diol" with the CAS number 2381979-66-2 is a complex organic compound characterized by its tetrahydroisoquinoline structure, which is a bicyclic framework commonly found in various natural products and pharmaceuticals. This compound features multiple functional groups, including hydroxymethyl and diol moieties, which contribute to its potential reactivity and solubility in polar solvents. The specific stereochemistry indicated by the (1S,4R) configuration suggests that it has distinct spatial arrangements that may influence its biological activity and interactions with other molecules. Such compounds are often studied for their potential therapeutic effects, particularly in the context of neurological and cardiovascular diseases. The presence of hydroxyl groups typically enhances hydrogen bonding capabilities, which can affect the compound's pharmacokinetics and binding affinity to biological targets. Overall, this substance represents a class of compounds with significant interest in medicinal chemistry and drug development.

(1S,4R)-1-(Hydroxymethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-4,6-diol

2381979-66-2: The chemical substance known as "(1S,4R)-1-(Hydroxymethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-4,6-diol" with the CAS number 2381979-66-2 is a complex organic compound characterized by its tetrahydroisoquinoline structure, which is a bicyclic framework commonly found in various natural products and pharmaceuticals. This compound features multiple functional groups, including hydroxymethyl and diol moieties, which contribute to its potential reactivity and solubility in polar solvents. The specific stereochemistry indicated by the (1S,4R) configuration suggests that it has distinct spatial arrangements that may influence its biological activity and interactions with other molecules. Such compounds are often studied for their potential therapeutic effects, particularly in the context of neurological and cardiovascular diseases. The presence of hydroxyl groups typically enhances hydrogen bonding capabilities, which can affect the compound's pharmacokinetics and binding affinity to biological targets. Overall, this substance represents a class of compounds with significant interest in medicinal chemistry and drug development.

CAS 2381979-66-2

(1S,4R)-1-(Hydroxymethyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-4,6-diol

(1S,4R)-4,6-Dihydroxy-1-(hydroxymethyl)-N-methyl-1,2,3,4-tetrahydroisoquinoline

Ref: 86-MM0081.29